Pfizer has reported nearly $37 billion in COVID vaccine sales in just 2021 alone. The CEO of Pfizer noted that COVID extermination is improbable, with several scientists earlier suggesting that newer vaccines were adding to the rise of variations.
- EXPLOSIVE: Here’s what was uncovered in Hunter Biden’s iCloud Hack
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
In 2021, Pfizer claimed $36.78 billion in worldwide sales and alliance revenue from their abortion-tainted COVID vaccination, leading to more than double earnings across its business activities contrasted to 2020.
In an earnings report released Tuesday, the pharmaceutical behemoth predicted that revenues of its vaccine and antiviral medication would reach $54 billion in 2022, boosting investors’ expectations that profits would rise for the second year running.
Despite concerns from several scientists that the usage of messenger RNA technology has major risks, Pfizer CEO Albert Bourla stated the organization aims to vigorously broaden the employment of messenger RNA beyond COVID vaccinations, alluding to possible treatments of muscle, liver, and neurological system.
Amidst its record earnings, Pfizer’s stock sank 3% on Wall Street yesterday thanks to comparatively low 2022 sales predictions for Paxlovid, the antiviral drug it offers for $530 per course in the United States.
Subscribe to GreatGameIndia
Whenever obtainable, antiviral medications like ivermectin, which health officials have attempted to ban or limit, often retail for just a few dollars, with numerous scientists claiming the tablets are much more effective than those manufactured by Pfizer.
Pfizer estimates that total revenues throughout the company’s product lines might exceed $102 billion in 2022.
“In the early days of the COVID-19 pandemic, we committed to use all of the resources and expertise we had at our disposal to help protect populations globally against this deadly virus, as well as to offer treatments to help avoid the worst outcomes when infections do occur,” Bourla said yesterday. “We put billions of dollars of capital on the line in pursuit of those goals, not knowing whether those investments would ever pay off.”
On Twitter, numerous commenters reacted to the earnings by mentioning how helpful mass vaccination campaigns had been to the company’s balance sheet.
Pfizer’s vaccine for the Omicron version will not be available for circulation before March, according to Bourla, putting more skepticism on requests from health authorities and major media sources to vaccinate individuals now with injections designed for previous variants.
Because of mutations and the virus’s global spread, the CEO noted that COVID extermination is improbable, with several scientists earlier suggesting that newer vaccines were adding to the rise of variations.
Last Monday, Dr. Michael Yeadon, a former Pfizer vice president and top scientist for respiratory research, called on the media to repent for their “lies” regarding vaccine safety after leaked military data revealed a 300 percent spike in miscarriages in 2021.
Yeadon, who worked 32 years in the pharmaceutical sector managing novel medications research before retiring with one of the most senior research post in his profession, was one of the authors of a petition (read below) to the European Medicines Agency (EMA) in December 2020 that expressed serious concerns about the absence of adequate testing of the experimental COVID-19 gene-based vaccinations prior to their emergency usage approvals.
In response to the concern that the shots would jeopardize women’s fertility, Yeadon and his colleague, Dr. Wolfgang Wodarg, wrote, “There is no indication whether antibodies against spike proteins of SARS viruses would also act like anti-Syncytin-1 antibodies. However, if this were to be the case, this would then also prevent the formation of a placenta which would result in vaccinated women essentially becoming infertile.”
According to the experts, such a scenario would have to be ruled out by conventional experimentation before forcing such medications on the entire community.
“It’s important to note that none of these gene-based agents had completed what’s called ‘reproductive toxicology,’” Yeadon wrote in his recent statement. “Over a year later, this battery of tests in animals still has not been done. So there was and still is no data package supporting safety in pregnancy or prior to conception.”
The Centers for Disease Control and Prevention (CDC) published statistics in December revealing that 965,843 reports of adverse outcomes following COVID vaccinations were filed to the Vaccine Adverse Event Reporting System (VAERS) between December 14, 2020, and December 10, 2021.
Over the same time period, there were 20,244 reports of fatalities and 155,506 reports of severe injuries, including deaths.
Of the 9,295 deaths documented in the United States as of December 10, 2021, 21% happened within 24 hours of vaccination, 26% within 48 hours of vaccination, and 61% occurred in those who developed symptoms within 48 hours of immunization.
Read Dr. Michael Yeadon’s full petition below: